Company
CVE:MKN
Makena is a junior exploration company dedicated to the aggressive pursuit of world class mineral deposits. Several upcoming project milestones make this an exciting time period for Makena’s corporate growth potential. Makena's Patterson Uranium Prospect consists of two claim blocks totaling 3,014 hectares (7,447 acres), which are located in the Athabasca Basin.
85 stories · page 3 of 5
Builders and building materials
A bullish business outlook and financial guidance boosted shares of Willow Biosciences Inc Wednesday plus other big percentage movers on news from the small and micro cap space
"We welcome the opportunity to advance Kalsec's range of natural, sustainable products while also evolving Willow's business strategy," said CEO Dr Peter Seufer-Wasserthal
"The third quarter saw us take another step forward in becoming a leader in precision fermentation," said the company's newly confirmed president and CEO, Dr Peter Seufer-Wasserthal
"We are pleased to add astaxanthin as the next functional ingredient to our product portfolio,” said Willow CEO Dr Peter Seufer-Wasserthal
"As we expand our portfolio of products and partnerships, we also remain committed to maximizing the value of our first functional ingredient, CBG, through continued development, operational improvements, and marketing efforts," said Willow
"The second quarter saw us take the next step in the evolution of our product portfolio with a new partnered pharmaceutical project," said Dr Peter Seufer-Wasserthal, interim president and CEO of Willow
The Vancouver-based company also said Willow director Barbara Munroe has been appointed as lead independent director
The move will enable Willow’s team to engineer strains more rapidly to give its researchers invaluable time to focus on intelligent library design and data analysis, the Vancouver-based company said
"This new partnership highlights the capabilities of our scientific team, and demonstrates to our stakeholders the wide array of opportunities accessible to Willow's comprehensive FutureGrown technology platform,” said Willow CEO Trevor Pet
Willow Biosciences CEO Trevor Peters said the company had a strong balance street and a world-class research and development team set up to capture value for shareholders
A new manufacturing services agreement with a contract development and manufacturing organization will help increase fermentation capacity to produce Willow’s FutureGrown platform
The company anticipates being able to add new compounds to its product offering in 2022 to generate revenue
The results of the Willow study were published in Molecules, a leading international, peer-reviewed, open-access journal
The Canadian company has developed a proprietary biosynthetic process to manufacture the cannabis compound in commercial quantities
For the last three months of 2021, Willow plans to continue to optimize its commercial process for the rare cannabinoid CBG and build out a robust order book for 2022, which it expects to be its first full year of commercial production and
Earlier this year, the bio manufacturer completed its first commercial-scale fermentation run of cannabigerol (CBG) through its manufacturing partner’s European facilities
The company inked its first multiyear commercial agreement with cosmetics firm Cellular Goods to supply CBG for its skincare line
The firm has scaled up its lead program, cannabigerol, to start manufacturing the highly valuable and rare cannabinoid at a commercial level
